How Breast Cancer Now helped discover PARP inhibitors

Breast Cancer Now
184
82 views

Transcript

The interactive transcript could not be loaded.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jun 5, 2017

Breast Cancer Now researchers played a crucial role in developing drugs called PARP inhibitors, which are designed to target cancer cells with specific BCRA faults. Professor Andrew Tutt and Dr. Chris Lord at the Institute of Cancer Research in London explain more. Find out more: http://bit.ly/2qOnolz

When autoplay is enabled, a suggested video will automatically play next.

Up next

to add this to Watch Later

Add to